Angiotensin-converting enzyme inhibitor-related angioedema: how to deal with it
- 15 August 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 5 (5) , 643-649
Abstract
Angiotensin-converting enzyme inhibitor-related angioedema is a well documented condition, which seems to occur in up to 1% of treated patients. It represents a problem for both the clinician and the patient: for the clinician, the diagnosis may be difficult due to its peculiar clinical characteristics, whereas for the misdiagnosed patient the delay prolongs a potentially dangerous situation. If the drug is not discontinued, the attacks tend to become worse and even life-threatening. There are now evidences that increased levels of bradykinin have an important role in the pathophysiology of attacks and, moreover, there are genetic factors that render certain individuals susceptible to angiotensin-converting enzyme inhibitor-related angioedema. In this review, the authors analyse the pathogenetic mechanism, the clinical presentation, the management and future perspectives of research on this condition.Keywords
This publication has 61 references indexed in Scilit:
- Pattern of hospitalizations for angioedema in New York between 1990 and 2003Annals of Allergy, Asthma & Immunology, 2005
- Dual ACE and Neutral Endopeptidase InhibitorsDrugs, 2003
- Angiotensin II receptor antagonists role in arterial hypertensionJournal of Human Hypertension, 2002
- Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-BradykininThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Hereditary angioedema first apparent in the ninth decade during treatment with ACE inhibitorAnnals of Allergy, Asthma & Immunology, 2001
- Unmasking of acquired autoimmune C1-inhibitor deficiency by an angiotensin-converting enzyme inhibitorAnnals of Allergy, Asthma & Immunology, 2001
- Angiotensin converting enzyme inhibitor-induced angioedema: a report of two casesPediatric Nephrology, 1999
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- ACE Inhibitor???Induced AngioedemaDrug Safety, 1998
- Angiotensin‐converting enzyme inhibitor‐induced angioedema: late onset, irregular course, and potential role of triggersAllergy, 1997